Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Psychemedics (PMD)

Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,738
  • Shares Outstanding, K 5,894
  • Annual Sales, $ 22,100 K
  • Annual Income, $ -4,150 K
  • EBIT $ -3 M
  • EBITDA $ 0 M
  • 60-Month Beta 0.65
  • Price/Sales 0.73
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.51
  • Most Recent Earnings $-0.09 on 11/12/24
  • Next Earnings Date 11/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 0.070 on 05/24/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/14
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.16
  • Growth Rate Est. (year over year) +624,275.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +28.99%
on 12/04/24
3.25 -17.85%
on 12/06/24
+0.34 (+14.35%)
since 11/12/24
3-Month
2.07 +28.99%
on 12/04/24
3.25 -17.85%
on 12/06/24
+0.36 (+15.33%)
since 09/12/24
52-Week
1.63 +63.80%
on 08/08/24
3.93 -32.06%
on 01/05/24
-0.22 (-7.61%)
since 12/12/23

Most Recent Stories

More News
Insider Purchase: 10% owner at $PMD (PMD) Buys 7,473 Shares

Anderson Capital Partners LLC Powell, a 10% owner of $PMD ($PMD), bought 7,473 shares of the company on 12-10-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This...

PMD : 2.67 (-1.84%)
Insider Purchase: Director at $PMD (PMD) Buys 1,409,712 Shares

Peter Kamin, a director at $PMD ($PMD), bought 1,409,712 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

PMD : 2.67 (-1.84%)
Psychemedics Corporation Announces 1-for-5,000 Reverse Stock Split Followed by 5,000-for-1 Forward Stock Split

Psychemedics Corporation announces a 1-for-5,000 reverse stock split followed by a 5,000-for-1 forward stock split effective December 3, 2024.Quiver AI SummaryPsychemedics Corporation announced that its...

PMD : 2.67 (-1.84%)
Psychemedics Corporation Announces Reverse and Forward Stock Split

PMD : 2.67 (-1.84%)
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

PMD : 2.67 (-1.84%)
Psychemedics: Q3 Earnings Snapshot

Psychemedics: Q3 Earnings Snapshot

PMD : 2.67 (-1.84%)
Psychemedics Corporation Reports Third Quarter 2024 Financial Results

PMD : 2.67 (-1.84%)
Psychemedics: Q2 Earnings Snapshot

Psychemedics: Q2 Earnings Snapshot

PMD : 2.67 (-1.84%)
Psychemedics: Q1 Earnings Snapshot

Psychemedics: Q1 Earnings Snapshot

PMD : 2.67 (-1.84%)
Psychemedics: Q3 Earnings Snapshot

Psychemedics: Q3 Earnings Snapshot

PMD : 2.67 (-1.84%)

Business Summary

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.

See More

Key Turning Points

3rd Resistance Point 3.12
2nd Resistance Point 2.94
1st Resistance Point 2.81
Last Price 2.67
1st Support Level 2.50
2nd Support Level 2.32
3rd Support Level 2.19

See More

52-Week High 3.93
Fibonacci 61.8% 3.05
Fibonacci 50% 2.78
Last Price 2.67
Fibonacci 38.2% 2.51
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar